In a recent multicenter prospective study conducted at three hospitals in Tennessee and Georgia, including Vanderbilt ...

For decades, doctors have worked to protect people from Streptococcus pneumoniae, a bacterium responsible for pneumonia, ...

Pfizer’s PCV20 offers single-shot protection against 20 pneumococcal serotypes, safeguarding adults from serious respiratory ...

Pfizer has launched its 20-valent pneumococcal conjugate vaccine (PCV20) in India, offering single-dose protection against 20 ...

A next-generation pneumococcal conjugate vaccine, PCV20, a single-dose protection is now available in India marking a new ...

New research has uncovered exactly how the bacterium Streptococcus pneumoniae has become resistant to the antibiotic penicillin. The same research could also open up MRSA to attack by penicillin ...

Study: Streptococcus pneumoniae re-emerges as a cause of community-acquired pneumonia, including frequent co-infection with SARS-CoV-2, in Germany, 2021. Image Credit: ThSucho/Shutterstock ...

Streptococcus pneumoniae is the leading bacterial cause of pneumonia, sepsis, and meningitis in children, which together comprise more than 25% of the 10 million deaths estimated to have occurred ...

VIENNA, April 7 -- Intercell announced today that a Phase I clinical trial with the company's vaccine candidate IC47 to prevent disease caused by the bacterium Streptococcus pneumoniae has started.

Streptococcus pneumoniae remains one of the most frequent bacterial causes of morbidity and mortality worldwide, causing a range of diseases including invasive infections such as bacteremia with ...